Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eli Lilly and Company Berne S.E.

Equities

LLY

US5324571083

Delayed Berne S.E.
Other stock markets
 09:30:02 16/04/2024 pm IST 		5-day change 1st Jan Change
684.5 CHF -1.23% Intraday chart for Eli Lilly and Company -2.83% +40.38%
05:13pm ETF of the week: Investing in strong trends with the momentum theme Our Logo
03/07 Health Stocks Slip in Risk-On Trade -- Health Care Roundup DJ

Evolution of the average Target Price on Eli Lilly and Company

Price target over the last 5 years

History of analyst recommendation changes

e.4N85D_RAm_GHfnjZb6FklBL_PUbkpwaPdLdCQCn6nvg.rbZQNqM6y7r_LBSsNvcn7VyHUReGw1TlTPEzKXap07Gq62x3qy2iqfISTA~480309cfbf1645c6c861828c267587af

Analyst Recommendations on Eli Lilly and Company

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Wednesday; Tesla to Advance, Reddit to Decline MT
Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on Eli Lilly & Co. to $1,041 From $1,015, Maintains Buy Rating MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices MT
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed MT
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline MT
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral... Our Logo
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update DJ
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994 MT
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE… RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower MT
Jefferies Adjusts Price Target on Eli Lilly and Co. to $994 From $957 MT
Jefferies Adjusts Price Target on Eli Lilly to $957 From $925 MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740 MT
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915 MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline MT
Argus Adjusts Price Target on Eli Lilly to $840 From $770 MT
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540 MT
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target MT
JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850 MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813 MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1 USD
Average target price
870.3 USD
Spread / Average Target
-3.10%
High Price Target
1,041 USD
Spread / Highest target
+15.91%
Low Price Target
540 USD
Spread / Lowest Target
-39.87%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eli Lilly and Company

Jefferies & Co.
Goldman Sachs
Argus
Redburn Atlantic
China International Capital
JPMorgan Chase
Wolfe Research
Barclays
BMO Capital
Leerink Partners
Deutsche Bank Securities
Truist Securities
Wells Fargo Securities
Morgan Stanley
UBS
BofA Securities
DZ Bank
JEFFERIES Akash Tewari
Cantor Fitzgerald
Morningstar
Guggenheim
Daiwa Securities
Berenberg Bank
Citigroup
Credit Suisse
HSBC
TD Cowen
SVB Securities LLC
Cowen
Mizuho Securities

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Consensus Eli Lilly and Company